Implementation of CDK4/6 Inhibitors and its Influence on the Treatment Landscape of Advanced Breast Cancer Patients – Data from the Real-World Registry PRAEGNANT von Engler, Tobias, Fasching, Peter A., Lüftner, Diana, Hartkopf, Andreas D., Müller, Volkmar, Kolberg, Hans-Christian, Hadji, Peyman, Tesch, Hans, Häberle, Lothar, Ettl, Johannes, Wallwiener, Markus, Beckmann, Matthias W., Hein, Alexander, Belleville, Erik, Uhrig, Sabrina, Wimberger, Pauline, Hielscher, Carsten, Kurbacher, Christian M., Wuerstlein, Rachel, Untch, Michael, Taran, Florin-Andrei, Enzinger, Hans-Martin, Krabisch, Petra, Welslau, Manfred, Maasberg, Michael, Hempel, Dirk, Lux, Michael P., Michel, Laura L., Janni, Wolfgang, Wallwiener, Diethelm, Brucker, Sara Y., Fehm, Tanja N., Schneeweiss, Andreas

Volltext

Daily alternating administration of high‐dose alpha‐2b‐interferon and interleukin‐2 bolus infusion in metastatic renal cell cancer. A phase II study von Bergmann, Lothar, Fenchel, Klaus, Weidmann, Eckhart, Enzinger, Hans‐Martin, Jahn, Bernhard, Jonas, Dieter, Mitrou, Paris S.

Volltext

Inversio uteri aufgrund eines uterinen embryonalen Rhabdomyosarkoms von Denkl, Barbara, Decrinis, Claire, Heidorn, Timm, Lenhart, Markus, Enzinger, Hans-Martin

Volltext